Clinical Trials Directory

Trials / Unknown

UnknownNCT05422963

Multiple-Center Retrospective Study of Severe and Critical COVID-19 in Shanghai

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Ruijin Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study is to clarify the clinical characteristics of severe and critical COVID-19 from March 1st ,2022 to June 9th, 2022 in Shanghai and to explore the relationship between the characteristics and prognosis in these patients.

Detailed description

1. To Describe the clinical characteristics of severe and critical COVID-19. 2. To analyze the relationship between the clinical characteristics and their clinical prognosis; 3. To analyze the relationship between clinical intervention and their clinical prognosis.

Conditions

Timeline

Start date
2022-06-10
Primary completion
2023-06-10
Completion
2023-06-10
First posted
2022-06-21
Last updated
2022-06-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05422963. Inclusion in this directory is not an endorsement.